GDNF enhances the synaptic efficacy of dopaminergic neurons in culture
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Glial cell line‐derived neurotrophic factor (GDNF) is known to promote the survival and differentiation of dopaminergic neurons of the midbrain. GDNF also causes an enhancement of dopamine release by a mechanism which is presently unclear. Using isolated dopaminergic neurons of the rat ventral tegmental area in culture, we have tested the hypothesis that GDNF regulates the establishment and functional properties of synaptic terminals. Previous studies have shown that single dopaminergic neurons in culture can co‐release glutamate in addition to dopamine, leading to the generation of a fast excitatory autaptic current via glutamate receptors. Using excitatory autaptic currents as an assay for the activity of synapses established by identified dopaminergic neurons, we found that chronically applied GDNF produced a threefold increase in the amplitude of excitatory autaptic currents. This action was specific for dopaminergic neurons because GDNF had no such effect on ventral tegmental area GABAergic neurons. The enhancement of excitatory autaptic current amplitude caused by GDNF was accompanied by an increase in the frequency of spontaneous miniature excitatory autaptic currents. These observations confirmed a presynaptic locus of change. We identified synaptic terminals by using synapsin‐1 immunofluorescence. In single tyrosine hydroxylase‐positive neurons, the number of synapsin‐positive puncta which represent putative synaptic terminals was found to be approximately doubled in GDNF‐treated cells at 5, 10 and 15 days in culture. The number of such morphologically identified terminals in isolated GABAergic neurons was unchanged by GDNF. These results suggest that one mechanism through which GDNF may enhance dopamine release is through promoting the establishment of new functional synaptic terminals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81311-2 · Cited by 1,174
Characterization of a multicomponent receptor for GDNF
Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., et al. (1996) · Nature · doi:10.1038/382080a0 · Cited by 1,080
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A., & Hefti, F. (1995) · Nature · doi:10.1038/373339a0 · Cited by 654
Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy
Choi-Lundberg, D. L., Lin, Q., Chang, Y.-N., Chiang, Y. L., Hay, C. M., Mohajeri, H., Davidson, B. L., & Bohn, M. C. (1997) · Science · doi:10.1126/science.275.5301.838 · Cited by 625
GFRα1 Is an Essential Receptor Component for GDNF in the Developing Nervous System and Kidney
Cacalano, G., Fariñas, I., Wang, L.-C., Hagler, K., Forgie, A., Moore, M., Armanini, M., Phillips, H., Ryan, A. M., Reichardt, L. F., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80514-0 · Cited by 560
Trupp, M., Belluardo, N., Funakoshi, H., & Ibáñez, C. F. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03554.1997 · Cited by 503
GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
Kearns, C. M., & Gash, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01366-p · Cited by 379
Mandel, R. J., Spratt, S. K., Snyder, R. O., & Leff, S. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14083 · Cited by 331
Presynaptic Recording of Quanta from Midbrain Dopamine Neurons and Modulation of the Quantal Size
Pothos, E. N., Davila, V., & Sulzer, D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04106.1998 · Cited by 320
Dopamine neurons make glutamatergic synapses in vitro
Sulzer, D. L., Joyce, M. P., Lin, L., Geldwert, D., Haber, S. N., Hattori, T., & Rayport, S. (1998) · PubMed · doi:10.7916/d8-snm4-r132 · Cited by 316
Dopamine Neurons Make Glutamatergic Synapses In Vitro
Sulzer, D., Joyce, M. P., Lin, L., Geldwert, D., Haber, S. N., Hattori, T., & Rayport, S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04588.1998 · Cited by 304
Bilang-Bleuel, A., Revah, F., Colin, P., Locquet, I., Robert, J.-J., Mallet, J., & Horellou, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8818 · Cited by 297
Bowenkamp, K. E., Hoffman, A. F., Gerhardt, G. A., Henry, M. A., Biddle, P. T., Hoffer, B. J., & Granholm, A. E. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550402 · Cited by 290
Trudeau, L.-E., Emery, D. G., & Haydon, P. G. (1996) · Neuron · doi:10.1016/s0896-6273(00)80210-x · Cited by 228
Self-citationSoler, R. M., Dolcet, X., Encinas, M., Egea, J., Bayascas, J. R., & Comella, J. X. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09160.1999 · Cited by 172
Other neurotrophic factors: Glial cell line-derived neurotrophic factor (GDNF)
Saarma, M., & Sariola, H. V. (1999) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19990515/01)45:4/5<292::aid-jemt13>3.0.co;2-8 · Cited by 167
Granholm, A.-C., Reyland, M., Albeck, D., Sanders, L., Gerhardt, G., Hoernig, G., Shen, L., Westphal, H., & Hoffer, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03182.2000 · Cited by 161
Burke, R. E., Antonelli, M., & Sulzer, D. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020517.x · Cited by 156
Hebert, M. A., van Horne, C. G., Hoffer, B. J., & Gerhardt, G. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21275-7 · Cited by 138
Furshpan, E., Landis, S., Matsumoto, S., & Potter, D. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-04-01061.1986 · Cited by 135
Glazner, G. W., Mu, X., & Springer, J. E. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980202)391:1<42::aid-cne4>3.0.co;2-r · Cited by 117
Epileptiform activity in microcultures containing one excitatory hippocampal neuron
Segal, M. M. (1991) · Journal of Neurophysiology · doi:10.1152/jn.1991.65.4.761 · Cited by 104
GDNF Induces a Dystonia-like State in Neonatal Rats and Stimulates Dopamine and Serotonin Synthesis
Beck, K. D., Irwin, I., Valverde, J., Brennan, T. J., Langston, J. W., & Hefti, F. F. (1996) · Neuron · doi:10.1016/s0896-6273(00)80085-9 · Cited by 84
Modulation of an early step in the secretory machinery in hippocampal nerve terminals.
Trudeau, L., Fang, Y., & Haydon, P. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.12.7163 · Cited by 82
Self-citationDifferential effects of GDNF and BDNF on cultured ventral mesencephalic neurons
Feng, L., Wang, C.-Y., Jiang, H., Oho, C., Mizuno, K., Dugich‐Djordjevic, M. M., & Lu, B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00015-7 · Cited by 72
Trudeau, L., Doyle, R., Emery, D. G., & Haydon, P. G. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00046.1996 · Cited by 61
Self-citationMichel, F. J., & Trudeau, L. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00239-7 · Cited by 56
Self-citationLiou, J., Yang, R., & Fu, W. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.129bi.x · Cited by 55
Pong, K., Xu, R., Baron, W., Louis, J., & Beck, K. D. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71051912.x · Cited by 54
Cited by
From glutamate co-release to vesicular synergy: vesicular glutamate transporters
El Mestikawy, S., Wallén-Mackenzie, Å., Fortin, G. M., Descarries, L., & Trudeau, L.-E. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2969 · Cited by 385
“Patch-clamp recordings of isolated rat mesencephalic dopamine neurons in microculture provided the first evidence that CNS dopamine neurons could form axon terminals capable of releasing glutamat”
BackgroundSelf-citationGlutamatergic neurons are present in the rat ventral tegmental area
Yamaguchi, T., Sheen, W., & Morales, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05263.x · Cited by 367
Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C.-C., Wilson, B., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 351
Mesocorticolimbic Glutamatergic Pathway
Yamaguchi, T., Wang, H.-L., Li, X., Ng, T. H., & Morales, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1598-11.2011 · Cited by 332
“The corelease of glutamate and DA from TH neurons has been suggested from in vitro and in vivo findings (Sulzer et al., 1998; Bourque and Trudeau, 2000; Joyce and Rayport, 2000; Sulzer and Rayport, 2000; Chuhma et al., 2004, 2009; Stuber et al., 2010; Tecuapetla et al., 2010).”
MethodGlutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens
Tecuapetla, F., Patel, J. C., Xenias, H., English, D., Tadros, I., Shah, F., Berlin, J., Deisseroth, K., Rice, M. E., Tepper, J. M., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0265-10.2010 · Cited by 310
“This possibility was first suggested on the basis of colocalization of tyrosine hydroxylase (TH) and glutamate in midbrain DAergic neurons as well as autaptic glutamatergic EPSCs in DAergic neurons in midbrain cell culture (Sulzer et al., 1998; Bourque and Trudeau, 2000).”
BackgroundInfluential
Metadata
- Authors
- Bourque, M., & Trudeau, L.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 12
- Issue
- 9
- Pages
- 3172-3180
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2069866761
- Cited by
- 162
- References
- 30
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.